Search Results 791-800 of 17565 for Assay

  1. Controlled Trial Evaluating Avacopan in C3 Glomerulopathy - Mayo Clinic

    ... assay. Currently on dialysis or likely will require dialysis within 7 days after screening. History or presence of any form of cancer within the 5 years ...

  2. Projects - Molecular Analysis of Human Diseases Laboratory - Mayo Clinic Research

    Using a variety of laboratory models and assays, we have confirmed the importance of this gene in these forms of cancer and have demonstrated that down ...

  3. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  4. Study to Evaluate the Efficacy And Safety of Tak-861 for the Treatment of Narcolepsy With Cataplexy - Mayo Clinic

    ... assay]. Exclusion Criteria: The participant has a current medical disorder, other than narcolepsy with cataplexy, associated with EDS. The participant: (a) ...

  5. Publications - Aoife M. Egan, M.B., B.Ch., Ph.D. - Mayo Clinic

    ... assay. Am J Physiol Endocrinol Metab. 2025 Jan 1; 328 (1):E62-E68 Epub 2024 Dec 09. View PubMed; Dunne F, Newman C, Alvarez-Iglesias A, O'Shea P, Devane D ...

  6. A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer - Mayo Clinic

    No prior DNA-repair gene defect results from the same assay performed on a Janssen-sponsored interventional trial; No more than 90 days of prior abiraterone ...

  7. Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders

    This collaboration shows that Oxford Nanopore's technology is ready to support development and validation of assays for clinical care, and it underscores ...

  8. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Undetectable HIV load by standard PCR clinical assay;; Absolute CD4 count of ≥200 mm3;; Willing to maintain adherence to combination antiretroviral therapy ...

  9. Uncovering Signaling Pathways That Regulate Invasion and Metastasis of Cancer Cells - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    Current research in the laboratory focuses on developing assays that can be clinically used to determine PKD1 and PKD3 expression in patient samples. The ...

  10. Cheryl L. Tran, M.D. - Mayo Clinic Faculty Profiles

    Utility of timely ADAMTS13 activity assay in management of thrombotic microangiopathy (TMA). Dr. Tran assesses the utility of timely availability of ...